The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 1942 | 2022 |
Biology, risk stratification, and therapy of pediatric acute leukemias: an update CH Pui, WL Carroll, S Meshinchi, RJ Arceci Journal of clinical oncology 29 (5), 551-565, 2011 | 1160 | 2011 |
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours X Ma, YU Liu, Y Liu, LB Alexandrov, MN Edmonson, C Gawad, X Zhou, ... Nature 555 (7696), 371-376, 2018 | 749 | 2018 |
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel U Creutzig, MM van Den Heuvel-Eibrink, B Gibson, MN Dworzak, ... Blood, The Journal of the American Society of Hematology 120 (16), 3187-3205, 2012 | 682 | 2012 |
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions H Bolouri, JE Farrar, T Triche Jr, RE Ries, EL Lim, TA Alonzo, Y Ma, ... Nature medicine 24 (1), 103-112, 2018 | 681 | 2018 |
Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia S Meshinchi, WG Woods, DL Stirewalt, DA Sweetser, JD Buckley, TK Tjoa, ... Blood, The Journal of the American Society of Hematology 97 (1), 89-94, 2001 | 660 | 2001 |
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial JE Rubnitz, H Inaba, G Dahl, RC Ribeiro, WP Bowman, J Taub, S Pounds, ... The lancet oncology 11 (6), 543-552, 2010 | 642 | 2010 |
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia DL Stirewalt, KJ Kopecky, S Meshinchi, FR Appelbaum, ML Slovak, ... Blood, The Journal of the American Society of Hematology 97 (11), 3589-3595, 2001 | 553 | 2001 |
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis ML Loh, S Vattikuti, S Schubbert, MG Reynolds, E Carlson, KH Lieuw, ... Blood 103 (6), 2325-2331, 2004 | 498 | 2004 |
Clinical implications of FLT3 mutations in pediatric AML S Meshinchi, TA Alonzo, DL Stirewalt, M Zwaan, M Zimmerman, ... Blood 108 (12), 3654-3661, 2006 | 472 | 2006 |
Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase … AS Gamis, TA Alonzo, S Meshinchi, L Sung, RB Gerbing, SC Raimondi, ... Journal of Clinical Oncology 32 (27), 3021-3032, 2014 | 450 | 2014 |
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group MR Loken, TA Alonzo, L Pardo, RB Gerbing, SC Raimondi, BA Hirsch, ... Blood, The Journal of the American Society of Hematology 120 (8), 1581-1588, 2012 | 308 | 2012 |
The genetic basis and cell of origin of mixed phenotype acute leukaemia TB Alexander, Z Gu, I Iacobucci, K Dickerson, JK Choi, B Xu, ... Nature 562 (7727), 373-379, 2018 | 299 | 2018 |
Structural and functional alterations of FLT3 in acute myeloid leukemia S Meshinchi, FR Appelbaum Clinical Cancer Research 15 (13), 4263-4269, 2009 | 297 | 2009 |
Relationship of the 90-kDa murine heat shock protein to the untransformed and transformed states of the L cell glucocorticoid receptor. ER Sanchez, S Meshinchi, W Tienrungroj, MJ Schlesinger, DO Toft, ... Journal of Biological Chemistry 262 (15), 6986-6991, 1987 | 297 | 1987 |
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia DL Stirewalt, KJ Kopecky, S Meshinchi, JH Engel, ... Blood 107 (9), 3724-3726, 2006 | 294 | 2006 |
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia BF Goemans, CHM Zwaan, M Miller, M Zimmermann, A Harlow, ... Leukemia 19 (9), 1536-1542, 2005 | 290 | 2005 |
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance CM Zwaan, S Meshinchi, JP Radich, AJP Veerman, DR Huismans, ... Blood 102 (7), 2387-2394, 2003 | 290 | 2003 |
The incidence and clinical significance of nucleophosmin mutations in childhood AML P Brown, E McIntyre, R Rau, S Meshinchi, N Lacayo, G Dahl, TA Alonzo, ... Blood, The Journal of the American Society of Hematology 110 (3), 979-985, 2007 | 248 | 2007 |
Identification of genes with abnormal expression changes in acute myeloid leukemia DL Stirewalt, S Meshinchi, KJ Kopecky, W Fan, ... Genes, Chromosomes and Cancer 47 (1), 8-20, 2008 | 234 | 2008 |